title: Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.
abstract: Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.
authors.affiliation: Cardiovascular Division, University of Miami Miller School of Medicine, Miami, Florida 33101-5138, USA. rhershberger@med.miami.edu
authors.forename: Ray E
authors.initials: RE
authors.lastname: Hershberger
authors.forename: Joann
authors.initials: J
authors.lastname: Lindenfeld
authors.forename: Luisa
authors.initials: L
authors.lastname: Mestroni
authors.forename: Christine E
authors.initials: CE
authors.lastname: Seidman
authors.forename: Matthew R G
authors.initials: MR
authors.lastname: Taylor
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Towbin
mesh_terms: D009202:Cardiomyopathies / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology; D005817:Genetic Counseling; D005820:Genetic Testing; D006801:Humans; D018570:Risk Assessment; D012955:Societies, Medical; D014481:United States